Medicare Enrolled

Dr. Sumon Roy, MD

Interventional Cardiology · Brockton, MA
Research-focused
830 OAK ST, Brockton, MA 02301
5085834440
In practice since 2016 (10 years)
NPI: 1447601109 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Roy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Roy

Dr. Sumon Roy is an interventional cardiology specialist in Brockton, MA, with 10 years of NPI registration.

Between the years covered by Open Payments, Dr. Roy received a total of $37,482 from 11 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Roy is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice $37,482 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$37,482
Total received (2020-2024)
Avg $9,371/year across 4 years
Top 9% in MA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
11
Companies
137
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$29,481 (78.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,001 (21.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,626
2023
$24,118
2022
$8,708
2020
$31

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,870
Edwards Lifesciences Corporation
$1,344
Abbott Laboratories
$172
Novo Nordisk Inc
$94
ABIOMED
$63
Novartis Pharmaceuticals Corporation
$48
Alnylam Pharmaceuticals Inc.
$35
Top 3 companies account for 94.8% of 2024 payments
All-time payments by company (2020-2024) ›
Medtronic, Inc.
$32,350
ABIOMED
$2,292
Edwards Lifesciences Corporation
$1,344
Abbott Laboratories
$578
Boston Scientific Corporation
$284
Shockwave Medical, Inc
$151
Novartis Pharmaceuticals Corporation
$131
Janssen Pharmaceuticals, Inc
$118
LivaNova USA, Inc.
$105
Novo Nordisk Inc
$94
Alnylam Pharmaceuticals Inc.
$35
Top 3 companies account for 96.0% of all-time payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AngioJet Ultra 5000A · CG FUTURE · COREVALVE EVOLUT R · DIAMONDBACK CORONARY · DRAGONFLY OPSTAR · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · GENERAL - TACHY · Impella · LEQVIO · LIFESPARC · MITRACLIP · NC TREK NEO · ONPATTRO · OPTIS · Ozempic · RESOLUTE ONYX · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · XARELTO · XIENCE SIERRA · XIENCE SKYPOINT
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 9% for interventional cardiology in MA.

Looking for an interventional cardiology specialist in Brockton?
Compare interventional cardiologists in the Brockton area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists within 10 mi
41
Per 100K population
7.7
County median income
$109,698
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Roy is an interventional cardiology specialist, with research-focused industry engagement in the top 9% of MA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Roy receive payments from pharmaceutical companies?
Yes. Dr. Roy received a total of $37,482 from 11 companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Roy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →